Key concerns now

1. Ferritin 3000 ng/mL + persistent fever + hepatomegaly
   • Consider secondary HLH/macrophage activation syndrome (MAS), especially with underlying rheumatoid disease, but ferritin alone is not diagnostic.
   • Also consider adult-onset Still disease, occult infection, lymphoma, severe inflammatory response, and less likely hepatic injury as isolated AST/ALT are normal.
   • HLH can initially look like sepsis. Look particularly for falling platelets, falling Hb/WBC, coagulopathy, high triglycerides, low fibrinogen, splenomegaly, and worsening LFTs. HLH-2004 requires 5 of 8 criteria, but in adults the HScore is useful as an early probability tool.
2. HCO3 12 with pH 7.40 and tachypnea
   • This is not reassuring. It means a significant metabolic acidosis is being offset by respiratory alkalosis or compensation.
   • Calculate anion gap immediately:
     AG = Na - (Cl + HCO3)
   • Use Winter's expected PCO2:
     Expected PCO2 = 1.5 × HCO3 + 8 ± 2 = 26 ± 2 mmHg.
   • If actual PCO2 is much lower than about 24, he has an additional respiratory alkalosis, seen in sepsis/inflammation, salicylate toxicity, liver disease, pulmonary processes, etc.
   • Normal lactate does not explain bicarbonate 12. Check ketones, glucose, renal trend, chloride, albumin-corrected AG, and consider salicylate level/toxicology if clinically plausible.
3. Fever with conjugated hyperbilirubinemia and normal AST/ALT
   • Think of inflammatory or sepsis-related cholestasis, hemolysis plus another process, biliary infection/obstruction, malaria, enteric fever, rickettsial illness, viral infection, or infiltrative disease.
   • Obtain ALP, GGT, PT/INR, albumin, LDH, haptoglobin, reticulocyte count, and peripheral smear.

Practical work-up today

1. Reassess severity and look for a focus

• Repeat full examination daily: skin and eschar search including groin/axilla/scalp, rash during fever spike, arthritis/synovitis, lymph nodes, hepatosplenomegaly, cardiac murmur/stigmata of endocarditis, fundus if symptoms, and careful abdominal exam.
• Repeat vitals, mental status, urine output, capillary glucose, and serial CBC/platelets.
• Given RR 34 and bicarbonate 12, consider monitored/HD unit care if tachypnea or acidosis persists or worsens.

2. Microbiology before any antibiotic escalation, if feasible

• Two to three sets of blood cultures from separate peripheral sites, ideally during a spike. Antibiotics may reduce yield, but cultures are still worthwhile.
• Urine routine/microscopy and culture.
• Sputum culture/AFB/NAAT only if respiratory symptoms or imaging findings emerge.
• HIV Ag/Ab.
• Hepatitis B surface antigen, hepatitis C antibody, and consider hepatitis A/E IgM according to local epidemiology and clinical setting.
• COVID/influenza testing if relevant locally.
• Peripheral smear for malaria plus rapid malaria antigen. If initial smear is negative but suspicion remains, repeat smears over 24-48 h.
• Scrub typhus IgM ELISA or PCR. Do not rely on absence of eschar.
• Blood culture for enteric fever if appropriate. Widal and Weil-Felix are not reliable rule-in or rule-out tests and should not drive treatment.
• Consider Q fever, brucellosis, and leptospirosis repeat/PCR based on exposures: livestock, raw dairy, abattoir work, rodents, floods, ticks, travel, and occupation.
• TB testing should be targeted to symptoms/imaging/epidemiology. In India or other high-burden settings, disseminated TB remains important.

3. Hyperferritinemia / HLH-MAS screen urgently

• CBC with differential and daily platelet trend
• Peripheral smear
• Fasting triglycerides
• Fibrinogen
• D-dimer, PT/INR, aPTT
• LDH, uric acid
• Repeat ferritin in 24-48 hours, looking at trajectory
• LFT including ALP/GGT, albumin
• Consider soluble IL-2 receptor/sCD25 and NK-cell activity if available, but do not delay specialist assessment awaiting them.
• EBV PCR, CMV PCR, and other trigger-directed testing if accessible.
• Calculate HScore once the above data are available.
• Hematology input early. Bone marrow aspiration/biopsy is reasonable if cytopenias appear, smear is abnormal, HLH probability is moderate-high, or there is concern for lymphoma/leukemia. Absence of hemophagocytosis does not exclude early HLH.

4. Imaging

• Repeat chest radiograph if the respiratory rate remains high. A normal early CXR does not rule out PE, early pneumonia, miliary TB, or inflammatory lung disease.
• CT chest, abdomen and pelvis with contrast if renal function permits, especially with persistent fever, hepatomegaly, high inflammatory markers, and no source. Look for occult abscess, lymphadenopathy, splenic lesions, malignancy, TB, or vascular pathology.
• Echocardiography, preferably TTE first, if any murmur, embolic features, persistent bacteremia, prosthetic material, IVDU, or no alternative source. Proceed to TEE if endocarditis remains plausible.
• If routine work-up is unrevealing, FDG-PET/CT can help locate occult inflammatory, infectious, or malignant foci. Recent evidence supports its diagnostic use in selected persistent fever cases, including suspected Still disease (systematic review, PMID 40838726).

5. Rheumatologic assessment

• Quotidian or double-quotidian high spiking fever
• Evanescent salmon-pink rash with fever
• Sore throat
• Neutrophilic leukocytosis
• Arthralgia/arthritis
• Lymphadenopathy or hepatosplenomegaly
• Marked ferritin elevation

Antimicrobial and steroid caution

• Reassess whether piperacillin-tazobactam plus doxycycline matches the leading infectious hypotheses and local resistance pattern. A fall in TLC does not prove the current regimen is treating the cause.
• Do not broaden antibiotics blindly without obtaining cultures and imaging unless he becomes unstable.
• Avoid empiric corticosteroids solely for ferritin 3000 until infection and hematologic malignancy have been actively assessed. However, if he develops worsening organ dysfunction and a multidisciplinary team considers HLH/MAS highly probable, hematology/rheumatology may recommend urgent immunomodulatory treatment while trigger investigations continue.
• In HLH, treating an infectious trigger alone may not be sufficient once immune activation is established. Goldman-Cecil Medicine, 2-volume set, p. 4495-4502.

Immediate red flags for escalation

• Hypotension, altered sensorium, oliguria, rising creatinine
• Increasing respiratory work, hypoxemia, rising anion gap, or falling pH
• Platelet/Hb/WBC decline
• INR rise, fibrinogen fall, DIC
• Ferritin rapidly rising, especially into very high levels
• Splenomegaly, worsening bilirubin/LFTs, or new lymphadenopathy

What the reports show

• Patient age on reports: 47 years, not 42.
• Persistent neutrophilic leukocytosis is improving: WBC 14.84 to 12.22 x10³/µL.
• Hb has fallen: 11.6 to 10.4 g/dL, normocytic. Platelets remain normal: 328 to 345 x10³/µL.
• Therefore, at present he has only one cytopenic lineage, anemia, not the 2-line cytopenia required as an HLH-2004 criterion.
• Ferritin reported: 3000 ng/mL.
• Hepatosplenomegaly and fever are present.
• Bilirubin is improving: 2.9/1.4 to 2.1/1.2 mg/dL. AST/ALT and ALP are essentially normal. This is mild mixed, predominantly indirect hyperbilirubinemia rather than clear obstructive cholestasis.
• CRP 50.2 mg/L, ESR 99 mm/h.
• Urine: 1+ protein, only 2-4 WBC/hpf, no RBC. This does not suggest UTI.
• Creatinine 0.7, urea 22: preserved renal function.
• HbA1c 7.14%, so diabetes is present, but random sugar 169 alone does not explain the bicarbonate of 12.

Important correction: this is high-anion-gap metabolic acidosis

• Repeat ABG/VBG with measured PCO2
• Repeat Na, K, Cl, bicarbonate, Mg, phosphate
• Serum beta-hydroxybutyrate and urine ketones
• Serum osmolarity and calculated osmolar gap
• Salicylate level, if any possibility of ingestion
• Repeat lactate
• Glucose trend

HLH/MAS: next tests today

• Fever
• Splenomegaly
• Ferritin >500

1. Fasting triglycerides
2. Fibrinogen
3. PT/INR, aPTT, D-dimer
4. LDH, uric acid, reticulocyte count, peripheral smear
5. Daily CBC with platelet count, LFT, ferritin
6. sCD25/soluble IL-2 receptor if available
7. EBV PCR, CMV PCR, HIV Ag/Ab
8. Hematology review and calculate HScore once triglyceride, fibrinogen, AST, cytopenia status, and marrow status are available.

Priority differential diagnosis in this case

1. Secondary HLH/MAS

2. Occult infection

• Repeat 2-3 blood culture sets, despite prior antibiotics.
• Malaria antigen and 3 peripheral smears over 24-48 h.
• Scrub typhus IgM ELISA/PCR and examine carefully for eschar.
• HIV, hepatitis B/C, EBV/CMV.
• Consider TB work-up, including CT imaging and targeted sampling.
• Exposure-directed tests: brucella, Q fever, visceral leishmaniasis if compatible travel/exposure history.
• Weil-Felix and Widal should not be used to exclude or confirm these diagnoses. The low Widal titres shown are negative/noncontributory.

3. Lymphoma or hematologic malignancy

• Contrast CT chest-abdomen-pelvis
• Careful node examination
• Peripheral smear reviewed by hematopathologist
• LDH and uric acid
• Bone marrow aspiration/biopsy if HScore is concerning, cytopenias progress, smear is abnormal, or CT shows nodes/splenic lesions.

4. Inflammatory disease

• Quotidian fever pattern
• Sore throat
• Evanescent rash during spikes
• Myalgia and arthritis/synovitis
• Serositis

Management position now

• This needs ID + hematology input today, and rheumatology if infection/malignancy studies remain unrevealing or HScore rises.
• Do not start steroids purely because ferritin is 3000. If fibrinogen is low, triglycerides high, counts fall, ferritin rises rapidly, or organ dysfunction develops, discuss urgent HLH/MAS-directed treatment with hematology while investigating triggers.
• Continue to reassess the antibiotic plan based on cultures, imaging, exposure history, and clinical deterioration, rather than broadening blindly.
• The USG report itself is not visible among the attached images, but accepting the stated hepatosplenomegaly, it makes the CT chest-abdomen-pelvis and HLH panel higher priority.

Update interpretation

• Triglycerides 109 mg/dL: normal. This argues against active HLH/MAS, since hypertriglyceridemia is a common HLH feature.
• HIV I/II negative
• Renal function remains normal: creatinine 0.7 mg/dL
• Sodium corrected to 138 mmol/L
• Uric acid 3.4 mg/dL, not suggestive of high cell-turnover syndrome.

Where HLH/MAS stands now

• Persistent high fever
• Hepatosplenomegaly
• Ferritin around 3000 ng/mL
• Mild anemia
• Mild AST elevation around 43 U/L

• Hypertriglyceridemia
• Thrombocytopenia
• Neutropenia/leukopenia
• Renal failure
• Major hepatitis
• Documented hypofibrinogenemia
• Documented coagulopathy

Next decisive investigations

1. Fibrinogen, PT/INR, aPTT, D-dimer
   • Low fibrinogen would raise the probability of HLH/MAS substantially.
   • A very high D-dimer with falling fibrinogen/platelets would indicate evolving consumptive coagulopathy.
2. CBC, peripheral smear, ferritin daily
   • Watch especially for platelets <100,000, Hb <9 g/dL, neutrophils <1,000, or a rapidly increasing ferritin.
   • Ensure the smear is explicitly reviewed for malaria parasites, atypical cells/blasts, leukoerythroblastosis, and hemolysis.
3. LDH, reticulocyte count, haptoglobin, direct antiglobulin test
   • The predominantly indirect bilirubin component and falling Hb warrant assessment for hemolysis, even though this is not yet definitive.
4. CT chest-abdomen-pelvis with contrast
   • Persistent high fever plus hepatosplenomegaly and ferritin elevation needs imaging for occult lymphadenopathy, lymphoma, splenic/hepatic lesions, TB, abscess, or another inflammatory focus.
5. Infectious evaluation
   • Malaria rapid antigen plus repeat peripheral smears.
   • Repeat blood cultures, preferably during fever, though prior antibiotics reduce yield.
   • Scrub typhus IgM ELISA/PCR if not already sent.
   • EBV and CMV testing, ideally PCR where available.
   • TB work-up guided by CT findings and symptoms.
   • Brucella/Q-fever testing only if exposure history supports it.

Do not lose focus on the acidosis

• Repeat ABG/VBG with measured PCO2
• Serum bicarbonate and anion gap
• Beta-hydroxybutyrate or serum/urine ketones
• Glucose
• Serum osmolality/osmolar gap if unexplained
• Salicylate level if any possible drug exposure

Working clinical position

1. Occult infection, including malaria, scrub typhus, TB, endocarditis, viral trigger, and less commonly brucellosis/Q fever.
2. Lymphoma/hematologic disease, given fever plus hepatosplenomegaly.
3. Secondary hyperinflammatory syndrome, currently possible but not proven.
4. Adult-onset Still disease only after the above have been reasonably excluded, and only if fever pattern, pharyngitis, evanescent rash, arthralgia/arthritis, or serositis support it.

What this change could represent

Most urgent: septic arthritis

• New acute inflammatory mono/oligoarthritis, with demonstrable effusion
• CRP now 100 mg/L
• Rising neutrophilic leukocytosis
• Diabetes and possible RA treatment-related immunosuppression, if he uses steroids, methotrexate, biologics, JAK inhibitor etc.
• Recent systemic febrile illness

Other plausible causes

• RA flare: possible if he has true synovitis in several typical small and large joints, morning stiffness, and an interruption/failure of DMARD therapy. But RA flare alone does not safely explain the preceding prolonged high fever, ferritin 3000, hepatosplenomegaly, and substantial inflammatory response.
• Reactive arthritis / post-infectious arthritis: possible after an occult infection. Usually asymmetric oligoarthritis of lower limbs, but remains a diagnosis after septic arthritis is excluded.
• Crystal arthritis: gout/pseudogout can cause this presentation, even with normal serum uric acid. Serum uric acid 3.4 does not rule it out.
• Adult Still disease or RA-associated inflammatory activation: lower on the list until infection, including joint infection, has been excluded.

What to do today

Aspirate the right knee before steroids or intra-articular injection

1. Cell count and differential
2. Gram stain
3. Aerobic and anaerobic culture and sensitivity
4. Crystal analysis with polarized microscopy
5. Consider mycobacterial/fungal studies if there is compatible exposure, chronicity, or immunosuppression
6. If available, inoculate fluid into blood-culture bottles, which can improve yield in patients already receiving antibiotics.

Alongside aspiration

• Two sets of repeat blood cultures, ideally before the next antibiotic dose if clinically safe.
• Repeat CBC with differential, CRP, ESR, renal/liver function.
• Examine both knees carefully for warmth, erythema, marked pain on passive movement, and inability to bear weight.
• Ultrasound both knees to document and target the effusions.
• If aspiration shows inflammatory fluid but cultures are initially negative, reassess at 24-48 h. Do not give systemic steroids simply because crystals are present, as crystal arthritis and septic arthritis can coexist.
• Obtain the exact RA medication history. Current/recent prednisolone, methotrexate, leflunomide, anti-TNF drugs, rituximab, tofacitinib/baricitinib, etc. materially raise the infection risk and affect interpretation.

Steroid decision

• synovial fluid is nonpurulent,
• Gram stain/cultures remain negative,
• crystals are absent or an alternative inflammatory pattern is clear,
• blood cultures are negative,
• and there is convincing multi-joint inflammatory synovitis,

Overall interpretation

• WBC 15.2k/µL, neutrophils about 91%
• Hb 10.2 g/dL
• Platelets about 4.84 lakh/µL: reactive thrombocytosis is likely
• CRP 142.6 mg/L, rising from 50 to 100 to 143
• Bilirubin is improving to 1.7 mg/dL, but ALP is mildly raised at 134 U/L
• Blood culture has no growth at 48 hours, but it is only a preliminary aerobic result and he has already had antibiotics.

Imaging choice

Do contrast CT chest-abdomen-pelvis first

• Intra-abdominal/hepatic/splenic abscess
• Abdominal or mediastinal lymphadenopathy
• Lymphoma or other malignancy
• TB-related nodes, lung lesions, splenic lesions
• Occult pneumonia, empyema, septic emboli
• Hepatosplenic architecture and portal/vascular abnormalities
• Occult pelvic source

PET-CT is reasonable, but after CT CAP or if CT CAP is readily unavailable

• Occult infection, including skeletal infection
• TB
• Lymphoma
• Large-vessel vasculitis
• Inflammatory arthritis/Still disease
• A suitable lymph node or lesion to biopsy

Do not delay knee aspiration for imaging

• Synovial total leukocyte count and differential
• Gram stain
• Aerobic and anaerobic culture
• Crystal analysis under polarized light
• Mycobacterial culture/NAAT and fungal studies if the fluid is lymphocyte-predominant, the course is indolent, imaging suggests TB, or he is immunosuppressed
• Inoculate synovial fluid into blood-culture bottles if available

Additional actions during the next fever spike

1. Take two blood-culture sets from separate peripheral sites before the next antimicrobial dose, if clinically safe.
2. Ensure the existing culture is followed to the final 7-day report, including anaerobic status if it was sent.
3. Repeat malaria smear/rapid antigen if not already repeated adequately.
4. Obtain LDH, fibrinogen, D-dimer, PT/INR, peripheral smear, and repeat ferritin. This helps reassess lymphoma/HLH-MAS, though normal triglycerides and preserved platelets make HLH less likely currently.
5. Obtain detailed RA medication history. Active prednisolone, methotrexate, leflunomide, anti-TNF therapy, rituximab, or a JAK inhibitor increases the likelihood of opportunistic and disseminated infection.

Bottom line

What the new reports show

PET-CT

• Mildly FDG-avid small nodes in bilateral cervical level II, mediastinal, pelvic and inguinal stations:
  • SUV values roughly 1.8 to 3.5
  • Nodes retain fatty hilum
  • Report impression: reactive nodes, not a clear lymphoma pattern.
• Mild hepatosplenomegaly, with diffuse splenic uptake: SUVmax 4.25.
• Diffuse bone-marrow FDG uptake: SUVmax 8.09.
• Symmetric inflammatory uptake around both knees and ankles, with synovial thickening/fluid: compatible with inflammatory arthritis.
• Small right lower-lobe subpleural inflammatory/infective-appearing opacity, SUVmax 3.11, with minimal bilateral pleural effusions.
• Bilateral tonsillar uptake, left more than right, reported as infective/inflammatory.

Bone marrow

• Normocellular marrow
• Mild myeloid hyperplasia, fitting a reactive neutrophilic inflammatory state
• No abnormal cells/blasts
• No dysplasia
• No granulomas
• Megakaryocytes normal
• No reported hemophagocytosis

Interpretation

1. Major systemic inflammatory flare related to RA, with active bilateral knee/ankle synovitis and reactive marrow/nodal/splenic activation.
2. Adult-onset Still disease-like systemic inflammatory syndrome, possibly overlapping with pre-existing RA, particularly given spiking fever, neutrophilic leukocytosis, ferritin around 3000, hepatosplenomegaly, high CRP, and new inflammatory arthritis.
3. Occult infection remains incompletely excluded, especially:
   • Right lower-lobe inflammatory focus
   • Tonsillitis/dental-ENT focus
   • Culture-negative endocarditis, if compatible clinical features
   • Septic arthritis, until synovial fluid culture has been addressed
   • TB is less likely after negative marrow granulomas and no focal PET pattern, but not excluded solely by PET/marrow.

HLH/MAS is now less likely

Is this simply an RA flare?

• New symmetric large-joint inflammatory involvement on PET supports active inflammatory arthritis.
• Reactive nodes, reactive marrow, and splenic uptake can be secondary to inflammation.
• However, the preceding 2-3 week high fever, marked CRP rise, hepatosplenomegaly, and small lung/tonsillar inflammatory abnormalities demand exclusion of an infectious trigger before corticosteroid or intensified DMARD treatment.

Most useful next steps

1. Aspiration of the right knee effusion, if not already done:
   • Synovial WBC count and differential
   • Gram stain, aerobic/anaerobic culture
   • Crystal examination
   • Consider mycobacterial testing if the clinical course or fluid suggests it
     Do this before systemic steroids where feasible.
2. ENT examination
   • Inspect left tonsil carefully for exudate, abscess, dental infection, or chronic tonsillitis.
   • Throat swab/culture only if clinical pharyngotonsillitis is present.
   • The PET finding alone is not enough to assign the fever to tonsillitis.
3. Reassess the right lower-lobe lesion
   • Review PET-CT diagnostic CT lung windows with radiology.
   • Correlate with cough, sputum, pleuritic pain, saturation, and repeat chest X-ray or HRCT only if clinically indicated.
   • If respiratory symptoms are absent and the lesion is tiny, it may be nonspecific inflammatory change.
4. Infective endocarditis screen if any clinical clue
   • Repeat blood cultures off or before next antibiotic dose if possible.
   • Echocardiography if murmur, embolic signs, persistent recurrent fever, poor dentition, or culture-negative endocarditis is a concern.
5. Rheumatology-led inflammatory assessment
   • Document tender/swollen joint count, morning stiffness, rash during fever, sore throat, myalgia, and serositis.
   • Check ANA, anti-CCP, repeat RF, ferritin trend, LDH, fibrinogen, and triglycerides.
   • Review all RA medication exposure and timing, especially methotrexate, leflunomide, steroids, anti-TNF drugs, rituximab, or JAK inhibitors.
6. Node biopsy is not the first next test
   • The nodes are small, mildly avid, and radiologically reactive. Marrow is nonmalignant.
   • Consider excisional biopsy only if a node enlarges, develops high FDG uptake, becomes hard/fixed, or fever/inflammation continues despite exclusion of infection and treatment of inflammatory disease.

Practical conclusion